MetasTx Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $400K

  • Investors
  • 8

MetasTx General Information

Description

Operator of a healthcare firm intended to create novel therapies to treat and prevent metastasis of cancer. The company specializes in creating treatments that prevent and treat prostate cancer metastasis without the devastating effects of androgen deprivation therapies, enabling patients with a well-known enzyme to be pivotal in cancer initiation and metastasis and is majorly expressed in prostate, breast, and skin cancers.

Contact Information

Website
www.metastx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 100 South Jackson Avenue
  • Pittsburgh, PA 15202
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 100 South Jackson Avenue
  • Pittsburgh, PA 15202
  • United States

MetasTx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MetasTx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 25-Jun-2025 $400K Completed Pre-Clinical Trials
5. Accelerator/Incubator 02-Oct-2024 Completed Pre-Clinical Trials
4. Later Stage VC (Series B) Cancelled Pre-Clinical Trials
3. Accelerator/Incubator 07-Dec-2023 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 22-Nov-2023 $150K $400K Completed Pre-Clinical Trials
1. Early Stage VC 01-Dec-2022 $250K $250K Completed Pre-Clinical Trials
To view MetasTx’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

MetasTx Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

MetasTx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250144046-A1 Pharmaceutical compositions and methods of administration Pending 28-Jan-2022
WO-2023147478-A2 Pharmaceutical compositions and methods of administration Inactive 28-Jan-2022
WO-2023147478-A3 Pharmaceutical compositions and methods of administration Inactive 28-Jan-2022 A61K31/10

MetasTx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MetasTx Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Cancer Institute Government
Peachscore + Gust Accelerator Program Accelerator/Incubator
AlphaLab Health Accelerator/Incubator Minority
Innovation Works Venture Capital Minority
Accelerator Venture Partners Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

MetasTx FAQs

  • When was MetasTx founded?

    MetasTx was founded in 2021.

  • Where is MetasTx headquartered?

    MetasTx is headquartered in Pittsburgh, PA.

  • What is the size of MetasTx?

    MetasTx has 7 total employees.

  • What industry is MetasTx in?

    MetasTx’s primary industry is Drug Discovery.

  • Is MetasTx a private or public company?

    MetasTx is a Private company.

  • What is MetasTx’s current revenue?

    The current revenue for MetasTx is .

  • How much funding has MetasTx raised over time?

    MetasTx has raised $500K.

  • Who are MetasTx’s investors?

    National Cancer Institute, Peachscore + Gust Accelerator Program, AlphaLab Health, Innovation Works, and Accelerator Venture Partners are 5 of 8 investors who have invested in MetasTx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process